Prelude Capital Management, LLC Nautilus Biotechnology, Inc. Transaction History

Prelude Capital Management, LLC

  • $1.57 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$1.67 - $2.77 $5,678 - $9,418
-3,400 Reduced 19.6%
13,944 $38,000
Q3 2022

Nov 14, 2022
BUY
$1.96 - $3.13 $33,994 - $54,286
17,344 New
17,344 $37,000
Q3 2021

Nov 15, 2021
SELL
$6.14 - $10.1 $303,930 - $499,950
-49,500 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$9.04 - $14.19 $447,479 - $702,405
49,500 New
49,500 $500,000

Others Institutions Holding NAUT

# of Institutions
86
Shares Held
64.3M
Call Options Held
1.9K
Put Options Held
100
View Full List

About Nautilus Biotechnology, Inc.

NAUT Quotes by TradingView
  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $299M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email